Letter: tenofovir may be superior to entecavir for treatment-naïve chronic hepatitis B patients

Aliment Pharmacol Ther. 2021 May;53(9):1048-1049. doi: 10.1111/apt.16323.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use
  • Carcinoma, Hepatocellular* / drug therapy
  • Guanine / analogs & derivatives
  • Hepatitis B virus
  • Hepatitis B, Chronic* / drug therapy
  • Humans
  • Liver Neoplasms* / drug therapy
  • Tenofovir / therapeutic use

Substances

  • Antiviral Agents
  • entecavir
  • Guanine
  • Tenofovir